BMEA
Biomea Fusion, Inc.
Next earnings Aug 3, 2026 · consensus $-0.23 EPS
Last earnings +1.9% on 2026-05-11
$1.32
▲ +7.32%$1.32▼ -21.89%
over 1Y
L $0.96EODHDH $2.67
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+7.3%
1W+7.3%
1M-2.9%
3M+0.0%
YTD-1.5%
1Y-21.9%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 13 analysts
Buy
Conservative balance sheet (liabilities/equity 0.98x).
Return on equity -209.1% · latest
Biomea Fusion, Inc. shows limited reported revenue, and -209.1% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$41.7M | -$83.6M | -$126M | -$144M | -$83.5M |
| Net income | -$41.6M | -$81.8M | -$117M | -$138M | -$61.8M |
| Diluted EPS | -$1.74 | -$2.80 | -$3.44 | -$3.83 | -$1.18 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$39.6M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-64.8%
FCF yield-74.1%
Quality & risk
ROIC (est.)-223.2%
Free cash flow-$70.7M
Total debt—
Net cash$55.8M
Piotroski F-Score2/6
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+92.4%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRoutine disclosure cadence — no material red flags in recent filings.
Recent filings
all on EDGAR ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-102026-06-12open ↗8-KPeriod ending 2026-06-102026-06-11open ↗10-QPeriod ending 2026-03-312026-05-11open ↗8-KPeriod ending 2026-05-112026-05-11open ↗8-KPeriod ending 2026-04-272026-04-28open ↗DEF 14APeriod ending 2026-06-102026-04-27open ↗ARSPeriod ending 2025-12-312026-04-27open ↗4Period ending 2026-04-012026-04-03open ↗4Period ending 2026-04-012026-04-03open ↗
Frequently asked
- Is Biomea Fusion, Inc. (BMEA) a buy?
- BMEA currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.98x).
- What is Biomea Fusion, Inc.'s quality score?
- BMEA scores 58.333333333333336/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001840439, latest 10-Q filed 2026-05-11) · EODHD · as of 6/22/2026, 11:36:37 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.